Ikos Cif LTD (CIK: 0001372270) is a financial institution headquartered at 1 Iacovou Tompazi Street, 201 Vashiotis Business Centre, Limassol, Cyprus 3107. The firm regularly files Form 13F with the U.S. Securities and Exchange Commission (SEC), disclosing its equity holdings and investment positions.
As of the latest reporting period (2016-09-30), the institution manages a portfolio valued at $16.66 M, comprising 133 distinct securities. Over its filing history, it has submitted 15 Form 13F reports.
To view the institution’s full SEC filing history:
🔗 View All SEC Filings
Q3 2016 — Top-10 concentration: 36.5%. Quarterly turnover: 61.2%. ▲ 101 new, +9 added, −23 reduced, ×93 exited.
| Name | Shares | Market Value | Weight | Change | Activity |
|---|---|---|---|---|---|
|
Nike
N/A
|
16,444 | $868,000 | 5.21% | ▲ 16,444 | New Buy |
|
Goldman Sachs Group
N/A
|
5,199 | $828,000 | 4.97% | ▲ 5,199 | New Buy |
|
Teva Pharmaceutical
N/A
|
16,171 | $766,000 | 4.60% | ▲ 16,171 | New Buy |
|
General Electric
N/A
|
21,300 | $641,000 | 3.85% | ▲ 21,300 | New Buy |
|
Marriott Intl INC Ne
N/A
|
8,982 | $604,000 | 3.62% | ▲ 8,982 | New Buy |
|
Baidu Com
N/A
|
2,897 | $543,000 | 3.26% | ▲ 2,897 | New Buy |
|
Applied Matls
N/A
|
17,083 | $506,000 | 3.04% | ▲ 17,083 | New Buy |
|
Dow Chem Co
N/A
|
8,840 | $462,000 | 2.77% | ▼ 12,107 | Reduce -57.8% |
|
Amgen
N/A
|
2,597 | $437,000 | 2.62% | ▲ 2,597 | New Buy |
|
Netease Com
N/A
|
1,735 | $423,000 | 2.54% | ▲ 1,735 | New Buy |